Research library
Prepared by Pillar Research
Retatrutide
Sources and editorial policyA 39-amino-acid triple agonist investigated at GIP, GLP-1 and glucagon receptors.
Evidence limits
This reference describes published research only. It is not treatment information, and it does not provide human-use or administration guidance.
Sources
For current strength, AUD price, purity, batch COA and Australian dispatch, see Retatrutide 10mg (Reta Peptide) product specifications.